
Preserving Public Trust
Institute of Medicine, Board on Health Sciences Policy, Committee on Assessing the System for Pr
₹4,146

Workshop Summary
by Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery Development and
Free delivery. Nothing extra to pay at checkout.
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary.
Description supplied by the publisher.